332 related articles for article (PubMed ID: 2159694)
1. Arrhythmias and mortality in congestive heart failure.
Kjekshus J
Am J Cardiol; 1990 May; 65(19):42I-48I. PubMed ID: 2159694
[TBL] [Abstract][Full Text] [Related]
2. Ventricular arrhythmias in congestive heart failure.
Chakko S; de Marchena E; Kessler KM; Myerburg RJ
Clin Cardiol; 1989 Sep; 12(9):525-30. PubMed ID: 2571440
[TBL] [Abstract][Full Text] [Related]
3. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.
Bigger JT
Circulation; 1987 May; 75(5 Pt 2):IV28-35. PubMed ID: 3552300
[TBL] [Abstract][Full Text] [Related]
4. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
5. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.
Packer M; Gottlieb SS; Kessler PD
Am J Med; 1986 Apr; 80(4A):23-9. PubMed ID: 2871753
[TBL] [Abstract][Full Text] [Related]
6. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: a prospective long term study of 200 patients.
Rouleau J; Shenasa M; de Champlain J; Nadeau R
Can J Cardiol; 1990 Dec; 6(10):453-60. PubMed ID: 2272001
[TBL] [Abstract][Full Text] [Related]
8. Genesis of arrhythmias in the failing heart and therapeutic implications.
Oakley C
Am J Cardiol; 1991 May; 67(12):26C-28C. PubMed ID: 2021115
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
[TBL] [Abstract][Full Text] [Related]
10. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
11. Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials.
Naccarella F; Naccarelli GV; Maranga SS; Lepera G; Grippo MC; Melandri F; Gatti M; Pazzaglia S; Spinelli G; Angelini V; Ambrosioni E; Borghi C; Giovagnorio MT; Nisam S
Curr Opin Cardiol; 2002 Jan; 17(1):6-18. PubMed ID: 11790928
[TBL] [Abstract][Full Text] [Related]
12. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.
Packer M; Gottlieb SS; Blum MA
Am J Med; 1987 Mar; 82(3A):4-10. PubMed ID: 2882674
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators.
Teerlink JR; Jalaluddin M; Anderson S; Kukin ML; Eichhorn EJ; Francis G; Packer M; Massie BM
Circulation; 2000 Jan 4-11; 101(1):40-6. PubMed ID: 10618302
[TBL] [Abstract][Full Text] [Related]
14. [Heart failure and arrhythmias: the role of ACE inhibitors].
Santini M; Cacciatore G; Ansalone G
Ann Ital Med Int; 1993 Oct; 8 Suppl():10S-13S. PubMed ID: 8117514
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
16. Congestive heart failure: what should be the initial therapy and why?
Chatterjee K
Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
[TBL] [Abstract][Full Text] [Related]
17. [Arrhythmias in chronic heart failure. Prognostic significance and treatment].
Koenig A; Chauvin M; Thévenin D; Brechenmacher C
Presse Med; 1991 May; 20(20):950-5. PubMed ID: 1676164
[TBL] [Abstract][Full Text] [Related]
18. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
Ramires FJ; Mansur A; Coelho O; Maranhão M; Gruppi CJ; Mady C; Ramires JA
Am J Cardiol; 2000 May; 85(10):1207-11. PubMed ID: 10802002
[TBL] [Abstract][Full Text] [Related]
19. [Heart failure].
Yonezawa M; Komuro I
Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
[TBL] [Abstract][Full Text] [Related]
20. Factors causing arrhythmias in chronic congestive heart failure.
Parmley WW
Am Heart J; 1987 Nov; 114(5):1267-72. PubMed ID: 3314442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
